VahatiCor
Santa Clara, California, United States · Biotechnology, Health Care, Medical
VahatiCor is a medtech company dedicated to transforming cardiac care for Coronary Microvascular Dysfunction (CMD). They are focused on developing innovative therapies, particularly the A-FLUX Reducer System®, which aims to enhance myocardial perfusion and relieve symptoms of angina for millions affected by CMD. The company is currently advancing clinical studies and preparing for pivotal trials t
Key facts
- Headquarters
- Santa Clara, California, United States
- Employees
- 15
- Industries
- Biotechnology, Health Care, Medical
- Status
- Private
- Website
- vahaticor.com
- Company page
Recent activity at VahatiCor
VahatiCor funding history
| Date | Round | Amount |
|---|---|---|
| Nov 2025 | Series B | $23.0M |
Leadership
- Harry D. Rowland, Ph.D., Chief Executive Officer
- Marwan Berrada, Founder
- Kevin Van Bladel, Chief Technology Officer
- Mark Niggli, Chief Commercial Officer
Verified email and direct lines for VahatiCor’s decision-makers are on Fundz. See plans
Employee benefit plans
VahatiCor files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
VahatiCor in the news
Companies similar to VahatiCor
- Swarm Oncology Ltd · Biotechnology, Health Care, Medical, Therapeutics
- Actinogen Medical · Biotechnology, Health Care, Medical, Therapeutics
- Diakonos Oncology · Biotechnology, Health Care, Medical, Therapeutics
- Racura Oncology · Biotechnology, Health Care, Medical, Therapeutics
- First Ascent Biomedical · Biotechnology, Health Care, Medical, Therapeutics
About VahatiCor: questions and answers
What does VahatiCor do?
VahatiCor is a medtech company dedicated to transforming cardiac care for Coronary Microvascular Dysfunction (CMD). They are focused on developing innovative therapies, particularly the A-FLUX Reducer System®, which aims to enhance myocardial perfusion and relieve symptoms of angina for millions affected by CMD. The company is currently advancing clinical studies and preparing for pivotal trials t
Where is VahatiCor headquartered?
VahatiCor is headquartered in Santa Clara, California, United States.
How many employees does VahatiCor have?
VahatiCor has about 15 employees.
Has VahatiCor raised funding?
Yes. Fundz has recorded 1 funding event for VahatiCor. The most recent, Series B of $23.0M, was in Nov 2025.
Who leads VahatiCor?
Harry D. Rowland, Ph.D. is a Chief Executive Officer at VahatiCor.
What is the latest news on VahatiCor?
On May 18, 2026, VahatiCor Appoints Harry D. Rowland, Ph.D., as Chief Executive Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy